CJSC R-Pharm is a Russian high-tech pharmaceutical enterprise founded in 2001 in Moscow. Nowadays, the company is involved in R&D, manufacturing, market access and distribution of pharmaceuticals used in hospital and specialty care. R-Pharm employs over 1,400 highly qualified specialists, has 28 branches across Russian Federation. Turnover reached $ 1,3 billion in 2010. These figures will grow steadily as far as the company’s own production facilities will be launched. Key areas of R-Pharm’s competence include: manufacturing of finished drugs and APIs, research and development of innovative pharmaceutical products and technologies, training and education for industry and health care specialists. R-Pharm specializes on deliveries of high-tech medicines required by the hospital sector of the health care industry. The company’s portfolio features medicines of various clinical pharmacological groups, including oncologic, hematologic, immunologic, antibacterial, antiviral (including HIV therapy), medicines applied for transplantation of organs, drugs to treat muscular sclerosis, hemophilia and diabetes, as well as neuromuscular relaxants, radiopaque contrast agents and anesthetics. R-Pharm Overseas, Inc., was founded in January 2011 in San Diego, CA to provide R-Pharm with cutting-edge R&D technologies, discovery platforms, drug development strategies in the US, Japan, China and Europe. R-Pharm Overseas, Inc. facilitates partnering of drug candidates and drug discovery and development technologies with US-based Pharmaceutical, biotech and Venture capital companies, and implements US-arm strategies of partnered molecules and projects.